Subscribe to RSS
DOI: 10.1055/s-0038-1654224
Intestinal Alkaline Phosphatase as a Thrombogenic and Platelet-Altering Factor in Rabbits[*]
Publication History
Publication Date:
24 July 2018 (online)
Summary
Purified intestinal alkaline phosphatase (AlPh), 10 mg/kg, was injected intravenously into rabbits. In normal animals, 1 min post-injection, averaged samples showed platelet count decreases to 50% of control values in whole blood and to 20% in centrifuged “platelet-rich” plasma. Small or large platelet aggregates were noted in the counting chambers, and a glass-bead platelet-adhesiveness test gave values at least twice that in the controls. The platelet changes were paralleled by shortening of an ear-lobe bleeding-time test and by an equally temporary shortening of the r and h values in thrombelastograms (TEG) of fresh whole blood. A very significant correlation, in the 1 min data, was with 4 + thrombosis in 30 min occluded test segments of mesenteric veins. Screening tests of coagulation and fibrinolysis were not significantly altered, and the same was true of various clotting factor assays, except perhaps for small changes which might be attributable to limited local clot formation.
15 min post-injection, platelet counts had risen again, no aggregates were noted, the TEG normalized, and the thrombosis test was negative.
In dicumarolized rabbits, the AlPh injections still elevated the serum alkaline phosphatase and caused the platelet alterations, but now without the thrombophilic changes.
Electrophoretic studies of AlPh isoenzyme distribution suggested that the significant post-injection elevations were not those in the total serum or beta-globvlin enzyme levels, but in a specific “gamma” isoenzyme, migrating cathodic to the ß-globulins.
The significance of the present experiments to the basic understanding and testings of thrombotic states is briefly discussed.
* Aided by Grants from the Royal Hellenic Research Foundation, Athens, Greece, and from the USPHS (NIH, No. HE 01510), Bethesda, Md.
-
References
- 1 Bachman F, Duckert F, Koller F. The Stuart-Prower factor assay and its clinical significance. Thrombos. Diathes. haemorrh. (Stuttg) 02: 24 1958;
- 2 Barrow E. M, Bulloch W. R, Graham J. B. A study of the carrier state for plasma thromboplastin component (PTC, Christmas factor) deficiency, utilizing a new assay procedure. J. Lab. clin. Med 55: 936 1960;
- 3 Bessey O. A, Lowry O. H, Brock M. J. A method for the rapid determination of alkaline phosphatase with five cubic millimeters of serum. J. biol. Chem 164: 321 1946;
- 4 Bounameaux Y. Recherches sur le mécanisme de la retraction du caillot et de la metamorphose visqueuse des plaquettes. Experientia 12: 355 1956;
- 5 Boyer S. H. Alkaline phosphatase in human sera and placentae. Science N.Y 134: 1002 1961;
- 6 Brecher G, Gronkite E. P. Morphology and enumeration of human blood platelets. J. appl. Physiol 03: 365 1950;
- 7 Clayton S, Gross M. J. The aggregation of blood platelets by catecholamines and by thrombin. J. Physiol 169: 82 1963;
- 8 Davey M. G, Lander H. Effect of adenosine diphosphate on circulating platelets in man. Nature (Lond) 201: 1037 1966;
- 9 Ferguson J. H. Thromboplastic enzymes, thrombokinase, thromboplastin, and blood clotting: A critical review. Hematol. Rev 01: 69 1968;
- 10 Ferguson J. H, Iatridis S. G, latridis P. G. Some platelet-plasma relations. Thrombos. Diathes. haemorrh. (Stuttg.) Suppl 26: 117 1967;
- 11 Fishman W. H, Green S, Inglis N. I. L-phenylalanine: an organ specific stereospecific inhibitor of human intestinal alkaline phosphatase. Nature (Lond) 198: 685 1963;
- 12 Gaarder A. M, Jonsen J, Laland S, Hellem A, Owren P. A. Adenosine diphosphate in red cells as a factor in the adhesiveness of human blood platelets. Nature (Lond) 192: 531 1961;
- 13 Hellem A. J. The adhesiveness of human blood platelets in vitro. Scand. J. clin. Lab. Invest 12 Suppl. 51, 1 1960;
- 14 Hovig T. Release of platelet-aggregating substance (adenosine diphosphate) from rabbit blood platelets induced by saline “extract” of tendons. Thrombos. Diathes. haemorrh. (Stuttg) 09: 264 1963;
- 15 Iatridis P. G, Ferguson J. H. The plasmatic atmosphere of blood platelets. Evidence that only fibrinogen, AcG, and activated Hageman factor are present on the surface of platelets. Thrombos. Diathes. haemorrh. (Stuttg) IS: 114 1965;
- 16 Iatridis P. G, Ferguson J. H. Effect of alkaline and acid phosphatase on clotting: Evidence that alkaline phosphatase enhances activation of factor IX by SF, and that acid phosphatase enhances plasmatic anti-SF. Thrombos. Diathes. haemorrh. (Stuttg) 15: 365 1966;
- 17 Iatridis P. G, Ferguson J. H. Experimental thrombosis in rabbits: Evidence that alkaline phosphatase enhances the thrombogenic effect of the injected ellagic acid. Thrombos. Diathes. haemorrh. (Stuttg) 16: 645 1966;
- 18 Iatridis S. G. Fibrinolysis and intravascular coagulation : Separate or associated mechanisms. Thrombos. Diathes. haemorrh. (Stuttg.) Suppl 20: 53 1966;
- 19 Iatridis S. G, Ferguson J. H. A two-stage assay method for Hageman factor activity. Thrombos. Diathes. haemorrh. (Stuttg) 08: 46 1962;
- 20 Iatridis S. G, Ferguson J. H. Effect of physical exercise on blood clotting and fibrinolysis. J. appl. Physiol 18: 337 1963;
- 21 Iatridis S. G, Ferguson J. H, Iatridis P. G, Mauldin R. Thrombogenic properties of Surface factor: Evidence for an anti-Surface factor activity in canine plasma. Thrombos. Diathes. haemorrh. (Stuttg) 12: 35 1964;
- 22 Iatridis S. G, Iatridis P. G, Ferguson II J. Roles of Surface factor and a plasma inhibitory activity (anti-SF) during experimental thrombosis in rabbits. Thrombos. Diathes. haemorrh. (Stuttg) 12: 489 1964;
- 23 Kitchener P. N, Neale F. G, Posen S, Brudenell-Woods J. Alkaline phosphatase in maternal and fetal sera at term and during puerperium. Amer. J. clin. Path 44: 652 1965;
- 24 Korner N. H. Distribution of alkaline phosphatase in serum protein fractions. J. clin. Path 15: 195 1962;
- 25 Langdell R. D, Wagner R. H, Brinkhous K. M. Effect of antihemophilic factor on one-stage clotting tests. J. Lab. clin. Med 41: 637 1953;
- 26 Latner A. L. In: Enzymes in Clinical Chemistry. Ruyessen R, Vandendriessche L. eds. Elsevier Publ. Co; Amsterdam: 1965: 110.
- 27 Lüscher E. F. Viscous metamorphosis of blood platelets and clot retraction. Vox Sang 01: 133 1956;
- 28 Marcus A. J, Zucker M. B. The Physiology of Blood Platelets. Grune & Stratton; N.Y: 1965
- 29 Morris C. D, Miller W. K. Studies on the modification of a method for determining platelet stickiness. S. Afr. J. med. Sci 31: 45 1966;
- 30 Newton M. A. A distinctive fraction of alkaline phosphatase in healthrand disease. J. clin. Path 19: 491 1966;
- 31 de Nicola P. Platelet count and thrombelastographic maximum amplitude in experimental thrombocythemias. Thrombos. Diathes. haemorrh. (Stuttg) 03: 615 1959;
- 32 Regoli D, Clark V. Prevention by adenosine of the effect of adenosine diphosphate on the concentration of circulating platelets. Nature (Lond) 200: 546 1963;
- 33 Sandler M, Bourne G. H. Histochemical studies of phosphatases separated by starch gel electrophoresis. Exp. Cell Res 24: 174 1961;
- 34 Swank R. L, Fellman J. H, Hissen W. W. Aggregation of blood cells by 5-hydroxytryptamine (serotonin). Circulât. Res 13: 392 1963;
- 35 Warnock M. L. Intestinal phosphatase and fat absorption. Proc. Soc. exp. Biol. (N. Y) 129: 768 1968;